REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 459 filers reported holding REPLIGEN CORP in Q1 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,756 | +11.9% | 206 | -0.5% | 0.00% | 0.0% |
| Q2 2023 | $29,282 | -25.4% | 207 | -11.2% | 0.00% | -25.0% |
| Q1 2023 | $39,228 | -0.1% | 233 | +0.4% | 0.00% | 0.0% |
| Q4 2022 | $39,280 | -6.5% | 232 | +2.7% | 0.00% | 0.0% |
| Q3 2022 | $42,000 | +13.5% | 226 | +0.4% | 0.00% | 0.0% |
| Q2 2022 | $37,000 | -72.6% | 225 | -68.7% | 0.00% | -50.0% |
| Q1 2022 | $135,000 | -25.0% | 719 | +5.9% | 0.01% | -27.3% |
| Q4 2021 | $180,000 | -12.2% | 679 | -4.4% | 0.01% | -21.4% |
| Q3 2021 | $205,000 | +412.5% | 710 | +255.0% | 0.01% | +366.7% |
| Q2 2021 | $40,000 | +2.6% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $39,000 | +2.6% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $38,000 | +26.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $30,000 | +20.0% | 200 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $25,000 | +31.6% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $19,000 | +5.6% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $18,000 | +20.0% | 200 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $15,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |